Comprehensive safety profile of dipeptidyl peptidase-4 inhibitors: a post-marketing study based on FAERS database using signal detection algorithms

Dipeptidyl peptidase-4 inhibitors (DPP-4 inhibitors) have acquired a foothold in managing type 2 diabetes mellitus, but few concerns have arisen regarding their overall safety profile. The aim of this study is to assess the potential risk of DPP-4 inhibitors by analyzing data from the FDA Adverse Ev...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Expert opinion on drug safety Ročník 24; číslo 12; s. 1 - 13
Hlavní autoři:	Yoosuf, Beema T, Favas KT, Muhammed, Dutta, Pinaki, Bansal, Dipika
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 23.04.2024
Témata:	Adverse Drug Reaction Reporting Systems - statistics & numerical data Algorithms Data Mining Databases, Factual Detection Algorithms Diabetes Mellitus, Type 2 - drug therapy Dipeptidyl-Peptidase IV Inhibitors - administration & dosage Dipeptidyl-Peptidase IV Inhibitors - adverse effects Humans Hypoglycemic Agents - administration & dosage Hypoglycemic Agents - adverse effects Product Surveillance, Postmarketing Retrospective Studies United States United States Food and Drug Administration United States Dipeptidyl peptidase-4 inhibitors type 2 diabetes mellitus signal detection pharmacovigilance signal detection algorithms
ISSN:	1474-0338, 1744-764X, 1744-764X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!